FDA Panel Unanimously Endorses Johnson & Johnson Covid-19 Vaccine

With Johnson & Johnson’s Covid-19 vaccine on the verge of being authorized for emergency use by the US Food and Drug Administration, Americans are taking another look at the vaccine and it’s data. And what they see might initially give them pause. For several months, public health experts have praised the approximately 95% efficacy seen in vaccines by Pfizer-BioNtech and Moderna. But the data surrounding the Johnson & Johnson vaccine, developed by the company’s vaccine arm, Janssen, falls short of that figure.

RELATED: “Gamechanger”: FDA panel unanimously endorses Johnson & Johnson vaccine, clearing way for final approval

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s